Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF)
Clinical trial NCT04229901 · TERMINATED
Trial details
- NCT number
- NCT04229901
- Sponsor
- Cellaion SA
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-21
- Primary completion
- 2024-05-10
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.